PPARγ is a nuclear receptor transcription factor that plays a key role in adipogenesis [52] and is a major therapeutic target for various diseases including obesity, dyslipidemia, type 2 diabetes mellitus, neurodegenerative disorders, and cancers [53]. Here, PPARG is linked to obesity disorder.